Home › Calculator › GPCR Dividend Calculator 2026
GPCR Dividend DRIP Calculator 2026
4.22% YieldHealthcareStructure Therapeutics Inc. · NASDAQ
Price: $47.34 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GPCR pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your GPCR snowball 📈
$10,000 in GPCR → $15.1K in 10 years · $51.09/month
About Structure Therapeutics Inc. (GPCR) — Dividend Analysis 2026
Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressing pulmonary and cardiovascular conditions. For example, ANPA-0073 is a biased agonist aimed at the apelin receptor, a GPCR linked to diseases like idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension. Another compound in their pipeline is LTSE-2578, an oral small molecule that acts as a lysophosphatidic acid 1 receptor antagonist, also being explored for the treatment of IPF. Established in 2016, the company was formerly known as ShouTi Inc. and is headquartered in South San Francisco, California.
Compare GPCR with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GPCR DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GPCR position with:
🌍 GPCR Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GPCR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.22% | 1.42% | $422 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.59% | 0.79% | $359 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.38% | 0.58% | $338 / yr |
| 🇬🇧 UK ISA | 0% | 4.22% | 1.42% | $422 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.85% | 1.05% | $385 / yr |
| 🇨🇦 TFSA | 0% | 4.22% | 1.42% | $422 / yr |
| 🇨🇦 CA Taxable | 25% | 3.17% | 0.37% | $317 / yr |
| 🇦🇺 Super (pension) | 15% | 3.59% | 0.79% | $359 / yr |
| 🇦🇺 AU Taxable | 30% | 2.95% | 0.15% | $295 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.11% | 0.31% | $311 / yr |
| 🇫🇷 FR Taxable | 30% | 2.95% | 0.15% | $295 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GPCR Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GPCR Dividend Payment Schedule
GPCR pays quarterly — 4 times per year. Next ex-div: TBD.
📊 GPCR vs Healthcare Benchmarks
How GPCR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GPCR sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GPCR Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-09-01 | 17,817 | $0.34 | $6.1K | ||
| C-Conversion | 2026-09-01 | 17,817 | — | — | ||
| M-Exempt | 2026-09-01 | 17,817 | $0.34 | $6.1K | ||
| C-Conversion | 2026-09-01 | 5,939 | — | — | ||
| Sale | 2026-09-01 | 1,300 | — | — | ||
| Sale | 2026-09-01 | 4,539 | — | — | ||
| Sale | 2026-09-01 | 100 | — | — | ||
| M-Exempt | 2026-08-18 | 11,817 | $0.34 | $4.0K | ||
| C-Conversion | 2026-08-18 | 11,817 | — | — | ||
| M-Exempt | 2026-08-18 | 11,817 | $0.34 | $4.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GPCR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Structure Therapeutics Inc. (GPCR) is currently trading at $47.34, 47% below its 52-week high. The current dividend yield is 4.22% based on an annual payout of $2.00 per share.
GPCR (Structure Therapeutics Inc.) — 4.22% Dividend Yield Analysis
Structure Therapeutics Inc. (GPCR) is a healthcare stock currently trading at $47.34 with a dividend yield of 4.22%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.